Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance.
about
Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistanceThe bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracilExpression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors.Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia CellsOverexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast CancerThe mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.Epigenetic perspectives on cancer chemotherapy response.Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines.In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells.Publication trend, resource utilization, and impact of the US National Cancer Database: A systematic review.The Role of Mitochondrial H+-ATP Synthase in Cancer.ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.F-box proteins involved in cancer-associated drug resistance.
P2860
Q28538139-375A3A39-6013-4320-91B8-6C429A3A68E2Q34607831-0FFA66B7-5BA2-49D5-9D79-79CB7BD97FF0Q36809594-2ECAEFD2-6CB4-43D6-B070-BFC827C5028AQ36953477-366FB5BC-8131-43A6-AC8C-7F23F40AB17AQ37636455-467D83E7-A3D3-4FA0-864A-B289C034AC43Q37743122-015A29E1-FE40-4E0F-AA55-39EBC44DC10CQ38071479-D996ACBE-5834-472A-B739-28BCC919C385Q38209574-029567FB-91D5-40E5-85F6-E539706E5D3AQ38915783-995E5281-A1EA-4381-A253-CC06BEE9FC08Q38972904-06F32824-5CF5-45CA-A710-C765A9762948Q39116591-09E4AE76-B602-4046-98A9-A543709C6008Q39694624-7DA5C751-FBC1-4342-BBBA-EA7AF0C58224Q42930719-86B13E57-B6F5-428E-A8D1-76F66BC44205Q52681469-7EB43B77-29BF-4252-A7EE-035E6BD01163Q54961032-23F92B2C-6B5C-44A4-9113-D913B124AD0BQ55070671-5384BBE3-47D3-426F-945F-EE699F4B71FCQ55253244-A403BB57-29B7-4712-B892-CBC88FFD9192
P2860
Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Down-regulation of mitochondri ...... ted with multidrug resistance.
@ast
Down-regulation of mitochondri ...... ted with multidrug resistance.
@en
Down-regulation of mitochondri ...... ted with multidrug resistance.
@nl
type
label
Down-regulation of mitochondri ...... ted with multidrug resistance.
@ast
Down-regulation of mitochondri ...... ted with multidrug resistance.
@en
Down-regulation of mitochondri ...... ted with multidrug resistance.
@nl
prefLabel
Down-regulation of mitochondri ...... ted with multidrug resistance.
@ast
Down-regulation of mitochondri ...... ted with multidrug resistance.
@en
Down-regulation of mitochondri ...... ted with multidrug resistance.
@nl
P2093
P921
P356
P1433
P1476
Down-regulation of mitochondri ...... ted with multidrug resistance.
@en
P2093
P304
P356
10.1093/ANNONC/MDP569
P577
2009-12-27T00:00:00Z